‘Don’t Apologize for Commercialization’: Biotech Legend Robert Langer Urges Pitt to Take More Risks
Pitt’s Senior Vice Chancellor for Research, Dr. Rob Rutenbar introduced MIT professor Robert Langer... Read more
Pitt’s Senior Vice Chancellor for Research, Dr. Rob Rutenbar introduced MIT professor Robert Langer... Read more
The University of Pittsburgh Office of Innovation and Entrepreneurship (OIE) teamed with its counterparts... Read more
BlueShpere Bio is developing oncology therapies tailored to individuals by unlocking the potential of T-cell receptor (TCR) T cell therapy.